91µ¼º½

Dr Benjamin Krishna

Unknown

Areas of interest

Ben's research asks how viruses persist in the body for life, despite an immune system built to clear them.

His work focuses on human cytomegalovirus, a herpesvirus carried by most of the world's population. In healthy people it causes no symptoms, because the virus remains latent inside white blood cells where the immune system cannot see it. But it can reactivate and cause serious disease in people whose immunity is compromised: transplant recipients, people living with HIV and newborns.

Ben's group studies what keeps the virus latent, and what activates it. They particularly focus on the physiological state of the infected cells, to find new drug targets to improve outcomes in vulnerable patients.

Current projects include:

  • How physiological hypoxia modulates HCMV latency and reactivation
  • How hypoxia-induced metabolic shifts facilitate reactivation
  • How proteasome inhibitors could be used to treat HCMV
  • How the HUSH complex controls HCMV latency and lytic growth

Teaching

Part 3: Pathogens

Research centres and groups

  • UK International Coronavirus Network
  • Microbiology Society (UK)
  • International Herpesvirus Workshop

Research projects

Research Funding

  • Wellcome Early Career Award (£400,000) "The role of hypoxia and cellular metabolism in the persistence and dissemination of human cytomegalovirus"
  • Enhancing Research Culture Award

Background

  • 2012: MBiochem Biochemistry, University of Oxford
  • 2017: PhD, Department of Medicine, University of Cambridge
  • 2017-2020: Postdoctoral Fellow, Genomic Medicine, Lerner Research Institute, Cleveland Clinic, USA
  • 2021-2022: Postdoctoral Research Associate, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge
  • 2023-2026: Wellcome Early Career Award Fellow, Jeffrey Cheah Biomedical Centre, University of Cambridge
  • 2026: Current Lecturer in Inflammation

Awards and honours

  • Lerner Research Institute Postdoctoral Excellence Award, Cleveland, USA
  • Sir Howard Dalton Young Microbiologist of the Year (2015)
  • Review Editor,ÌýFrontiers in Cellular and Infection Microbiology
  • Grant reviewer for the Rosetrees Trust and the ANRS International Scientific Evaluation Committee in Emerging Infectious Diseases

Professional bodies/affiliations

National Collaborators:

  • Professor James Nathan, University of Cambridge
  • Professor Mark Wills, University of Cambridge
  • Professor Paul Lehner, University of Cambridge

International Collaborators

  • Dr Eain Murphy, SUNY Upstate Medical University, USA
  • Professor Mirko Trilling, University of Duisburg-Essen, Germany

Selected publications

  • Krishna BA, Lim EY, Metaxaki M, Jackson SE, Mactavous L, NIHR BioResource, Lyons PA, Doffinger R, Bradley JR, Smith KGC, Sinclair J, Matheson NJ, Lehner PJ, Sithole N, Wills MR (2024) Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to Long Covid. Science Advances 10(8), eadi9379
  • Krishna BA, Humby MS, Miller WE, O’Connor CM. (2019) Human cytomegalovirus G-protein coupled receptor US28 promotes latency by attenuating c-fos. PNAS 116(5), 1755–1764.
  • Krishna BA, Wills MR, Sinclair JH. 2018 Advances in the treatment of cytomegalovirus. British Medical Bulletin 131 (1), 5-17
  • Krishna BA, Poole EL, Jackson SE, Smit MJ, Wills MR, Sinclair JH. Latency-associated expression of human cytomegalovirus US28 attenuates cell signaling pathways to maintain latent infection. (2017). MBio 8 (6), 10.1128/mbio. 01754-17.
  • Krishna BA, Spiess K, Poole EL, Lau B, Voigt S, Kledal T, Rosenkilde MM, Sinclair JH. (2017) Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein. Nature Communications 8, 14321.

Link to all my papers:

Impact, enterprise and outreach

Public engagement

Ben has written about virology and immunology for The Conversation. He has also provided expert comment for New Scientist, and National Geographic. His work has featured in Forbes,ÌýThe Financial TimesÌý²¹²Ô»åÌýThe Telegraph.

Publications

Loading your publications ...